Item 2.02. Results of Operations and Financial Condition.

On August 9, 2021, Idera Pharmaceuticals, Inc. (the "Company") issued a press release announcing the Company's financial results for the first quarter ended June 30, 2021. As set forth below, the Company is furnishing the press release as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Form 8-K, including the accompanying Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act"), or otherwise subject to the liability of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of the general incorporation language of such filing, except as shall be expressly set forth by specific reference in such filing.




  Item 9.01. Financial Statements and Exhibits.




(d) Exhibits.

See the Exhibit Index below, which is incorporated by reference herein.





Exhibit No.                      Financial Statements and Exhibits.
  99.1          Press Release by the Company, dated August 9, 2021, furnished in
              accordance with Item 2.02 of this Current Report on Form 8-K.

104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document)

© Edgar Online, source Glimpses